Enlivex Therapeutics Israeli Company
Enlivex Therapeutics is a clinical-stage company focused on macrophage reprogramming. The company intends to develop and commercialize a drug pipeline for macrophage reprogramming in solid cancers, sepsis, COVID-19, and other indications.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/enlivex-therapeutics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/enlivex-therapeutics
External links are provided for reference and verification purposes.